medigraphic.com
ISSN 1029-3019 (Electronic)

2013, Number 11

<< Back Next >>

MediSan 2013; 17 (11)

Diagnostic and surgical treatment of patients with nodular thyroid disorders

Dorimain P, Rodríguez FZ, Rodríguez SLP, Falcón VGC, Mustelier FHL

Language: Spanish
References: 20
Page: 8031-8042
PDF size: 160.23 Kb.


ABSTRACT

Introduction: the incidence of nodular disease and thyroid cancer increases ever more.
Objective: to identify the results of the diagnosis and surgical treatment in those affected by these clinical entities.
Methods: an applied observational, descriptive and longitudinal study was carried out in 204 patients operated on for nodular thyroid disorders in the General Surgery Department of "Saturnino Lora Torres" Provincial Teaching Clinical Surgical Hospital of Santiago de Cuba during the five year period 2007-2011.
Results: nodular lesions predominated in women and malignant tumor accounted for 34.3% of the series. The fine-needle aspiration cytology showed low sensitivity, besides appropriate specificity and diagnostic certainty. The intraoperative frozen biopsy was not available and imprint cytology was not performed in all operated patients. Furthermore, postoperative complications and dysphonia in particular were related to cancer, radical surgery and reoperations. There was only one dead, for a mortality of 0.5%.
Conclusions: diagnostic methods were not effective in the peroperative differentiation of the nature of nodules, for which it was determined that the presence of a cytopathologist is essential to increase the accuracy in diagnostic studies and avoid unnecessary reoperations.


REFERENCES

  1. Pedroza Ballesteros A. Manejo del nódulo tiroideo: revisión de la literatura. Rev Colomb Cir Bogotá. 2008; 23(2): 28-37.

  2. Bhargav PR, Mishra A, Agarwal G, Agarwal A, Pradhan PK, Gambhir S, et al. Longterm outcome of differentiated thyroid carcinoma: experience in a developing country. World J Surg. 2010; 34(1): 40–7.

  3. Pulcrano M, Boukheris H, Talbot M, Caillou B, Dupuy C, Virion A, et al. Poorly differentiated follicular thyroid carcinoma: prognostic factors and relevance of histological classification. Thyroid. 2007; 17(7): 639-46.

  4. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA. 2006; 295(18): 2164 –7.

  5. Pérez JA, Zamorano M, Torres M, Fuentes A, Mancilla M. Cáncer de tiroides pediátrico. Serie de casos. Rev Chil Cir. 2009: 61(1): 21-6.

  6. Mitchell I, Livingston EH, Chang AY, Holt S, Snyder WH 3rd, Lingvay I, et al. Trends in thyroid cancer demographics and surgical therapy in the United States. Surgery. 2007; 142(6): 823-8.

  7. Landa I, Robledo M. Association studies in thyroid cancer susceptibility: are we on the right track? J Mol Endocrinol. 2011; 47(1): 43–58.

  8. Margusee E, Benson CB, Frates MC, Doubillet PM, Larsen PR, Cibas ES, et al. Usefulness of ultrasonography in the management of nodular thyroid disease. Ann Intern Med. 2000; 133(9): 696-700.

  9. Cibas ES, Ali SZ, NCI Thyroid FNA State of the Science Conference. The Bethesda System for Reporting Thyroid Cytopathology. Am J Clin Pathol. 2009; 132(5): 658- 65.

  10. Mazeh H, Beglaibter N, Prus D, Ariel I, Freund HR. Cytohistologic correlation of thyroid nodules. Am J Surg. 2007; 194(2): 161–3.

  11. Astroza G, González M, Paladines P, Casas R. Correlación entre biopsia rápida operatoria y biopsia diferida de tiroides: Revisión de 10 años en el Hospital Barros Luco-Trudeau. Rev Chil Cir. 2006; 58(6): 410-3.

  12. Zúñiga S, Sanabria A. Complicaciones y recurrencia en el tratamiento del carcinoma papilar de tiroides. Experiencia del Instituto Nacional de Cancerología. Rev Colomb Cir Bogotá. 2007; 22(3):68-76.

  13. Ito Y, Miyauchi A, Inoue H, Fukushima M, Kihara M, Higashiyama T, et al. An observational trial for papillary thyroid microcarcinoma in japanese patients. World J Surg. 2010; 34(1): 28–35.

  14. Ortega Peñate JA. Adenoma Folicular del tiroides. Dilema diagnostico terapéutico. Rev Méd Electrón. 2006 [citado 1 Jul 2008]; 28(4). Disponible en: http://www.revmatanzas.sld.cu/revista%20medica/ano%202006/vol4%202006/tema 09.htm

  15. Smallridge RC, Marlow LA, Copland JA. Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies. Endocr Relat Cancer. 2009; 16(1): 17–44.

  16. Lobos A, Villagrán D, Opazo C, Cardemil F. Cáncer anaplásico de tiroides de manejo quirúrgico. Rev Chilena Cir. 2009; 61(5): 423-8.

  17. Mazzaferri EL. Management of low-risk differentiated thyroid cancer. Endocr Pract. 2007; 13(5): 498-512.

  18. American Cancer Society. Cancer facts and figures. 2008 [citado 1 Jul 2008]; 58(3): 268-79. Disponible en:http://www.cancer.org/acs/groups/content/@nho/documents /document/2008cafffinalsecuredpdf.pdf

  19. Pérez Ruiz L, Ros López S, Gudelis M, Latasa Gimeno JA, Artigas Marco C, Pelayo Salas A. Isthmectomy: a conservative operation for solitary nodule of the thyroid isthmus. Acta Chir Belg. 2007; 108(6): 699–701.

  20. Mercante G, Frasoldati A, Pedroni C, Formisano D, Renna L, Piana S, et al. Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients. Thyroid. 2009; 19(7): 707-16.




2020     |     www.medigraphic.com